Cambridge
Consultants and Esprit Capital Partners
announce creation of joint venture
fund
 |
| (L-R) Ray Edgson of Cambridge Consultants and Simon Cook of Esprit Capital Partners |
|
- The first new venture is expected in 2007
- Previous investments yield IRR in excess of 50%
Cambridge
Consultants, a leading technology-based
design and development company, announces
that it has created a new venture
fund of up to £10 million jointly
with Esprit Capital Partners. The
creation of the fund supports Cambridge
Consultants’ move to restart
its spin-out activities after a four
year gap and will be used to invest
exclusively in its own technology
ventures. Cambridge Consultants has
a track-record of creating and developing
successful start-up companies that
is second to none, with just four
of its spin-outs creating a value
in excess of £1 billion in the
last 7 years.
According to the British Venture Capital
Association survey of 2004, the upper
quartile performance of early stage
funds between 1999 and 2004 returned
a net IRR (internal rate of return)
of 9.6%. During the same period Cambridge
Consultants’ spin-out investments
produced an IRR in excess of 50%.
Not surprisingly, this performance
led to extremely strong competition
to partner with the company in the
creation of the new venture fund,
one that will see one new start up
company created every two years on
average.
Esprit Capital Partners, formed by
the recent merger of Cazenove Private
Equity and Prelude Ventures, won the
tender process due to its strength
in both investing in, and supporting,
early stage technology ventures, as
well as its ability to provide funding
for later stage growth. The team at
Esprit Capital Partners also brings
to bear significant experience in
investing in technology start ups,
including several from Cambridge Consultants.
These include Cambridge Silicon Radio
(CSR) whose market cap is approximately £1.1 billion, and Alphamosaic,
which was sold to Broadcom for $120
million just three years after start-up.
The new investment will be made by
Prelude Trust plc, the investment
trust that specialises in early stage
technology-based businesses, now managed
by Esprit Capital Partners.
Ray Edgson, Ventures Director at Cambridge
Consultants commented, “To make
a truly successful venture you need
three key ingredients – the
right people, the right technologies
and the right market conditions. With
confidence now restored in the global
technology markets, we believe that
it is people that make the essential
difference between average and truly
great new ventures. Our track record
of success in this area, and an IRR
in excess of 50%, shows that our unique
culture allows us to develop just
such people.”
Edgson continued, “We are able
to recruit some of the best engineers
in the world because of the stimulating
and creative environment we provide
as they develop throughout their careers.
However, whilst there is a structured
career path within the company, our
venturing model allows those who want
to exploit their entrepreneurial skills
to go on and start their own businesses,
whilst being supported by our established
networks and systems. It’s an
approach that has made us central
to the creation of today’s vibrant
technology cluster in the Cambridge
area, as well as making quite a few
millionaires.”
The aim of the new fund is to invest
exclusively in Cambridge Consultants’
own new ventures, following the company’s
success in this arena. The first new
venture is expected to appear in 2007.
Candidates for the next batch of ventures
are expected to come from a range
of Cambridge Consultants’ core
markets, including wireless technologies,
drug delivery, diagnostics, radar
and electronics.
Spin-outs from Cambridge Consultants
collectively employ almost 3,000 people,
many of whom are headquartered in
the Cambridge area. It is this pool
of successful technologists in one
area that has created what is often
referred to as the ‘Cambridge
Phenomenon’ or ‘Silicon
Fen’.
Simon Cook, CEO of Esprit Capital
Partners commented, “Naturally,
we are delighted to partner with Cambridge
Consultants to create this fund, which
reflects our core strategy of working
with, and investing in, early stage
hi-tech companies with global ambitions.
By combining both partners’ venture expertise, our aim is to deliver
a clutch of spin-outs over the next
few years that will carry on the tradition
of generating both employment and
wealth-creation for many in the region.”
Notes to Editors
Cambridge
Consultants has, for over
45 years, enabled its clients to turn
business opportunities into commercial
successes, whether launching first-to-market
products, entering new markets or
expanding existing markets through
the introduction of new technologies.
We develop breakthrough products,
create and license intellectual property,
and provide business consultancy in
technology critical issues for clients
worldwide.
With a team of over 200 engineers,
scientists and consultants, in offices
in Cambridge (UK) and Boston (USA),
we are able to offer solutions across
a diverse range of industries including
healthcare, industrial and consumer
products, automotive, transport, energy
and wireless communications.
The company has created over twenty
new ventures in the past twenty five
years, several of which have gone
on to achieve listing on the London
Stock Exchange, namely Domino, Xaar,
Prelude Trust, CSR and Vivid (sold
to Vectura). Other successful spin-offs
include Alphamosaic and Inca, who
have subsequently been acquired by
Broadcom for $123m and Dainippon Screen
for Euro 43.8m, respectively. Both
sales were achieved within five years
of the companies being formed. For
more information, visit www.CambridgeConsultants.com
Esprit Capital Partners
Esprit Capital Partners is a leading
venture capital investor focused on
technology, new media, telecoms, software
and life science/healthcare investments.
Esprit aims to provide superior returns
for investors in its funds by investing
in, and helping entrepreneurs to build
world class companies.
Esprit Capital Partners was created
by the merger of Cazenove Private
Equity and Prelude Ventures. Prelude
Ventures has been making successful
early stage investments in UK and
European technology and healthcare
businesses for 21 years and manages
Prelude Trust PLC. Cazenove Private
Equity has been active as a cross
stage investor in the European technology
market since 2000, making more than
30 investments in this time from it’s
limited partnership funds. Both firms
have a strong reputation for supporting
their investments throughout their
life cycle. The combination enables
Esprit to support leading entrepreneurs
in IT, telecoms, media, life science
and healthcare companies across Europe
at all stages of their business ambitions.
The Esprit team has helped to build
some of Europe’s most successful
venture exits of recent years. The
$225m sale of KVS to Veritas was voted
Exit of the Year at the Investor All
Star Awards, 2005. The $123m sale
of Alphamosaic to Broadcom was voted
Deal of the Year at the EVCA Awards,
2005. In 2004, FillFactory was sold
to Cypress Semiconductor for $100m.
The $65m sale of DNA Research Innovations
to Invitrogen in 2004 was the highest
realisation of a European life science
company for the previous two years.
Cazenove Private Equity was voted
Venture Capitalist of the Year at
the UK Technology Innovation and Growth
Awards, 2005.
Esprit has $500m (£285m) of
assets under management focused on
European venture capital and a combined
team with over 100 years of venture
capital experience. Esprit Capital
Partners has offices in London and
Cambridge, UK.